2019
DOI: 10.1590/0037-8682-0244-2018
|View full text |Cite
|
Sign up to set email alerts
|

Abstract: Introduction: Apart from masking the diagnosis of AIDS in patients with HIV/AIDS, human T-cell lymphotropic virus (HTLV), when present, also increases the risk of myelopathies and neurological disease in these patients. Methods: Disease prevalence was estimated by ELISA and confirmed by Western blot. Results: The coinfection rate was 1.5% (11/720); 10 of 11 patients had HTLV-1, and the remaining one had HTLV-2. The majority were male, over 40 years old, and of pardo color (ethnicity). Conclusions:There was no … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
14
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(14 citation statements)
references
References 8 publications
0
14
0
Order By: Relevance
“…After dropping from 8% in 1998 (Vallinoto et al, 1998) to the current 1.3% prevalence rate, the Pará state became similar to Mozambique (1.55%) (Augusto et al, 2017), lower than Nigeria (4.9%) (Nasir et al, 2015) but still higher than Sierra Leone, where no cases of HTLV coinfection was observed in PLWHA (Yendewa et al, 2019). In Brazil, this rate is relatively similar to the states of Piaú (1.61%) (de Oliveira et al, 2012), Pernambuco (1.5%) (Ribeiro et al, 2019), and Santa Catarina (1.1%) (Marcon et al, 2019) and just a bit above the State of Goiás (0.8%) (Kozlowski et al, 2016) and below Rio Grande do Sul (2.9%) (Galetto et al, 2014).…”
Section: Discussionmentioning
confidence: 87%
See 1 more Smart Citation
“…After dropping from 8% in 1998 (Vallinoto et al, 1998) to the current 1.3% prevalence rate, the Pará state became similar to Mozambique (1.55%) (Augusto et al, 2017), lower than Nigeria (4.9%) (Nasir et al, 2015) but still higher than Sierra Leone, where no cases of HTLV coinfection was observed in PLWHA (Yendewa et al, 2019). In Brazil, this rate is relatively similar to the states of Piaú (1.61%) (de Oliveira et al, 2012), Pernambuco (1.5%) (Ribeiro et al, 2019), and Santa Catarina (1.1%) (Marcon et al, 2019) and just a bit above the State of Goiás (0.8%) (Kozlowski et al, 2016) and below Rio Grande do Sul (2.9%) (Galetto et al, 2014).…”
Section: Discussionmentioning
confidence: 87%
“…An endogenous control (human albumin gene) and the non-homologous regions of the pol gene (186 bp) of HTLV-1 and HTLV-2 were used. The primers used were HTLV-1F 5 -GAACGCTCTAATGGCATTCTTAAAACC-3 ), HTLV-1R (5 -GTGGTTGATTGTCCATAGGGCTAT-3 ), HTLV-2F (5 -CAACCCCACCAGCTCAGG-3 ), HTLV-2R (5 -GGGAAGGTTAGGACAGTCTAGTAGATA-3 ), Albumin F (5 -GCTCAACTCCCTATTGCTATCACA-3 ), and Albumin R (5 -GGGCATGACAGGTTTTGCAATATTA-3 ) as previously described (Ribeiro et al, 2019). The probe sequences used were FAM-5 -ACAAACCCGACCTACCC-3 -NFQ (HTLV-1), FAM-5 -TCGAGAGAACCAATGGTATAAT-3 -NFB (HTLV-2), and FAM-5 -TTGTGGGTGTAATCAT-NFQ (Albumin) (Tamegão-Lopes et al, 2006).…”
Section: Real-time Pcrmentioning
confidence: 99%
“…Ribeiro [18] Cross-sectional Brazil 720 (11 co-infected) CD4+ count was higher in co-infected patients than mono-HIV-infected. Median of first HIV viral load was higher in mono-infected patients.…”
Section: Discussionmentioning
confidence: 97%
“…However, in our selected articles, this issue is under a debate. More studies claim that CD4+ count increases in co-infected individuals [18,27,29,31,36,39,41]. Nevertheless, some research reported similar CD4+ counts in co-infected and mono-infected patients [21,22,29,43].…”
mentioning
confidence: 99%
“…Coinfection of HTLV and HIV is common in areas endemic for HTLV because these viruses have similar transmission routes, such as unprotected sexual intercourse, breastfeeding, blood transfusion and organ/tissue transplantation, and injectable drug use [1]. Studies suggest that people living with HIV (PLWHIV) infected with HTLV-1 are more likely to develop myelopathies and neurological disease [2]. However, the effect of HTLV-2 in HIV-positive individuals is unclear [3].…”
Section: Introductionmentioning
confidence: 99%